Lenvima 12 mg

LENVIMA 12 MG capsules contain lenvatinib mesylate, a medication used to treat certain types of cancer. This oral medication is designed to target specific cancer cells and may be prescribed as part of a treatment plan.

LENVIMA 12 MG capsules are primarily used in the treatment of advanced forms of thyroid cancer, such as differentiated thyroid cancer that has spread to other parts of the body. It may also be used in combination with other treatments for certain types of kidney cancer. Lenvatinib mesylate works by inhibiting the growth of cancer cells, helping to slow the progression of the disease. Patients should consult their healthcare provider to determine if this medication is suitable for their specific condition.

Common effects of LENVIMA 12 MG capsules may include fatigue, nausea, and high blood pressure. Some patients may also experience diarrhea, decreased appetite, and weight loss. These effects can vary from person to person, and not everyone will experience them. It is important to discuss any concerns with a healthcare professional.

LENVIMA 12 MG capsules should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should consult their healthcare provider before using this medication.

LENVIMA 12 MG capsules may interact with other medications, including those that affect blood pressure, blood clotting, and certain antacids. It is important to inform your healthcare provider about all medications, supplements, and herbal products you are taking. Alcohol consumption should be discussed with a healthcare professional, as it may affect the efficacy and safety of the medication.